In this study, for the first time, we demonstrated modified FPR-mediated reactions of innate immune cells such as granulocytes and that altered signaling from membrane receptors to NADPH-oxidase initiated two FPR agonists in obesity resistance. The gene discussed is FPR1; the disease is obesity due to melanocortin 4 receptor deficiency.